Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Acarix AB

Market Cap 313M 32.85M 28.51M 26.28M 24.63M 46.01M 3.15B 46.97M 121M 1.52B 123M 121M 5.27B P/E Ratio 2026 *
-
P/E Ratio 2027 * -
Enterprise Value 313M 32.85M 28.51M 26.28M 24.63M 46.01M 3.15B 46.97M 121M 1.52B 123M 121M 5.27B EV / Sales 2026 *
16.4x
EV / Sales 2027 * 4.51x
Free-Float
80.16%
Yield 2026 *
-
Yield 2027 * -
1 day+1.93%
1 week+2.33%
Current month+3.94%
1 month+1.15%
3 months-5.04%
6 months-16.72%
Current year-1.49%
1 week 0.24
Extreme 0.2435
0.27
1 month 0.24
Extreme 0.24
0.28
Current year 0.22
Extreme 0.2245
0.33
1 year 0.22
Extreme 0.2245
0.47
3 years 0.17
Extreme 0.1688
0.64
5 years 0.17
Extreme 0.1688
1.87
10 years 0.17
Extreme 0.1688
26.8
Manager TitleAgeSince
Chief Executive Officer - 2024-01-31
Chief Operating Officer 62 2009-11-30
Chief Executive Officer 62 2018-02-22
Director TitleAgeSince
Director/Board Member 61 2019-12-31
Director/Board Member 50 2024-05-13
Director/Board Member - 2024-05-13
Change 5-day change 1-year change 3-year change Capi.($)
+1.93%+2.33%+8.87%-52.17% 32.85M
-2.50%-7.77%+10.88%-29.84% 16.47B
+6.03%-2.53%+28.65%+60.84% 1.67B
-0.32%-1.47%-31.12%+19.55% 1.11B
+4.37%-7.91%-54.50%-83.37% 961M
-1.20%-4.29%-24.95%-55.23% 635M
-0.07%-2.76%-47.53%-59.63% 561M
+4.75%+5.45%+26.49%-51.45% 465M
+0.47%-2.60%-54.83%-60.17% 391M
+4.62%-8.55%+47.79% - 337M
Average +2.51%-1.70%-9.03%-34.61% 2.26B
Weighted average by Cap. +2.10%-5.91%+4.62%-25.40%

Financials

2026 *2027 *
Net sales 19.1M 2M 1.74M 1.6M 1.5M 2.8M 192M 2.86M 7.39M 92.39M 7.51M 7.35M 321M 69.5M 7.28M 6.32M 5.83M 5.46M 10.2M 697M 10.41M 26.91M 336M 27.34M 26.75M 1.17B
Net income -28.9M -3.03M -2.63M -2.42M -2.27M -4.24M -290M -4.33M -11.19M -140M -11.37M -11.12M -486M 2.4M 252K 218K 201K 189K 352K 24.08M 360K 929K 11.61M 944K 924K 40.36M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
26-06-11 0.2640 kr +1.93% 622,775
26-06-10 0.2590 kr +1.97% 2,144,047
26-06-09 0.2540 kr +0.99% 1,375,606
26-06-08 0.2515 kr -2.52% 1,338,016
26-06-05 0.2580 kr 0.00% 1,462,935

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACARIX Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!